What is the effect of appointing a new agent or common representative in a PCT application?
This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.
Appointing a new agent or common representative in a PCT application generally has the following effects:
- Appointing a new agent automatically revokes any earlier appointment of an agent, unless otherwise indicated.
- Appointing a new common representative automatically revokes any earlier appointment of a common representative, unless otherwise indicated.
This is specified in MPEP 1808, which states:
“The appointment of an agent for the international phase in general automatically has the effect, unless otherwise indicated, of revoking any earlier appointment of an agent. The appointment of a common representative similarly has the effect, unless otherwise indicated, of revoking any earlier appointment of a common representative.”
It’s important to clearly indicate if you intend to maintain multiple agents or representatives when making new appointments.